⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRD News
Opus Genetics, Inc. Common Stock
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
globenewswire.com
IRD
Form 8-K
sec.gov
IRD
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
globenewswire.com
IRD
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
globenewswire.com
IRD
Form 8-K
sec.gov
IRD
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
globenewswire.com
IRD
Opus Genetics to Present at the Chardan Annual Healthcare Conference
globenewswire.com
IRD
Form 8-K
sec.gov
IRD
Big Pharma Setbacks Create a New Wave of Rebound Plays
globenewswire.com
NVS
NTHI
TNON
IRD
Four Biotech Stories Heating Up Right Now
globenewswire.com
NTHI
IRD
BIAF
TNON